J
JCR Pharmaceuticals Co Ltd
TSE:4552
JCR Pharmaceuticals Co Ltd
TSE:4552
Price:
648 JPY
-18.8%
Market Closed
Updated:
May 14, 2024
JCR Pharmaceuticals Co Ltd
Operating Expenses
|
JCR Pharmaceuticals Co Ltd
Operating Expenses Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
J
|
JCR Pharmaceuticals Co Ltd
TSE:4552
|
Operating Expenses
-¥23.1B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-11%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Expenses
-¥2.4T
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-8%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Expenses
-¥898.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-5%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Expenses
-¥1.2T
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Expenses
-¥253.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Expenses
-¥1.4T
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-8%
|
See Also
What is JCR Pharmaceuticals Co Ltd's Operating Expenses?
Operating Expenses
-23.1B
JPY
-23.1B
JPY
Based on the financial report for Dec 31, 2023, JCR Pharmaceuticals Co Ltd's Operating Expenses amounts to -23.1B JPY.
What is JCR Pharmaceuticals Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-11%
-11%
Over the last year, the Operating Expenses growth was -13%. The average annual Operating Expenses growth rates for JCR Pharmaceuticals Co Ltd have been -20% over the past three years , -15% over the past five years , and -11% over the past ten years .
You don't have any saved screeners yet
